The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

This summer’s family barbecue was supposed to be a celebration of sorts—coming together for the first time since the pandemic pulled the plug on group activities. But your joy was cut short by an ...

With a fresh endorsement from the FDA, the last of five major drug approvals has fallen into place for GSK in 2025. | Tuesday ...

Depemokimab-ulaa (Exdensur) is approved for severe asthma with an eosinophilic phenotype, offering protection with just two ...

Having a severe allergy doesn’t just affect physical health - it’s often the social isolation and mental toll of dealing with a somewhat ‘invisible condition’ that people with allergies also have to ...

Exdensur is the first and only ultra-long-acting biologic for patients with severe asthma with an eosinophilic phenotype.

Nobody quite knows what causes asthma—but experts say that urban dwellers often have a tougher time managing their symptoms, thanks to a variety of environmental exposures. Here are seven tips for ...

The FDA has approved GSK’s Exdensur (depemokimab-ulaa) as an add-on maintenance therapy for adolescents and adults with severe asthma characterized by an eosinophilic phenotype. 1 ...

Children living in the suburbs of Australia's major cities are twice as likely to have asthma compared to those living in the city, according to a new study that revealed a surprising health disparity ...

Asthma medication is most commonly dispensed via an inhaler (more info on inhaler options in just a minute). This is because inhaling these drugs allows them to directly interact with your airways (as ...